300 NORTH CAPITAL, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 193 filers reported holding SEATTLE GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
300 NORTH CAPITAL, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q1 2015$789,000
-6.2%
22,299
-14.8%
0.17%
-10.3%
Q4 2014$841,000
-13.5%
26,180
+0.1%
0.19%
-24.8%
Q3 2014$972,000
-53.0%
26,153
-51.6%
0.26%
-49.3%
Q2 2014$2,068,000
-12.4%
54,053
+4.4%
0.51%
-16.8%
Q1 2014$2,360,000
+21.8%
51,763
+6.6%
0.61%
+14.0%
Q4 2013$1,938,000
-12.4%
48,573
-3.8%
0.54%
+4.1%
Q3 2013$2,213,000
+163.5%
50,502
+89.1%
0.52%
+57.8%
Q2 2013$840,00026,7000.33%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Baker Brothers Advisors 51,046,060$2,892,270,00023.68%
Lagoda Investment Management, L.P. 88,615$5,021,0008.38%
Matrix Capital Management Company, LP 3,141,852$178,017,0005.90%
Opus Point Partners Management, LLC 19,127$1,084,0002.39%
EMORY UNIVERSITY 41,539$2,354,0001.86%
Capital International Sarl 238,100$13,491,0001.62%
Rhenman & Partners Asset Management AB 242,198$13,723,0001.57%
CAPITAL GUARDIAN TRUST CO 1,341,050$75,984,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 42,500$1,890,0001.17%
JGP Global Gestao de Recursos Ltda. 16,524$936,0001.14%
View complete list of SEATTLE GENETICS INC shareholders